Pharmaceutical formulation comprising a metaloporphyrin and method for its purification and use
View Patent ↗Pharmaceutical formulation for the prophylaxis, pretreatment and treatment of a poisoning caused by exposure to (either singly or as a mixture of agents) organophosphorus cholinesterase inhibitors, vesicating agents, polycyclic aromatic hydrocarbons, and aflatoxin B1. This invention is characterized by active substance comprised of a metaloporphyrin molecule with an associated metal moiety (Cu, Mg) of suitable purity and chemical composition to provide a bioavailable oral dosage form to attain predictable concentrations in target tissues and bodily fluids (plasma, bronchial secretions, etc.) sufficient to counteract the effects of toxic substances through chemical complexation or catalysis of toxin degradation. Although these metaloporphyrins are semisynthetic products of chlorophyll, the preferred starting material is chlorophyll a (Chla) extracted and purified from Spirulina pacifica or other sources. A specific method is invented to achieve a critical combination of purity and yield beyond those currently available.
1. A method for obtaining substantially pure chlorophyll from a suitable source comprising:
providing a material containing chlorophylls; and
obtaining substantially pure chlorophyll that is greater than 92% pure from the material by centrifugal partition chromatography.
2. The method according to claim 1 where the centrifugal partition chromatography is counter current chromatography.
3. The method according to claim 1 performed in dim light or no light conditions.
4. The method according to claim 1 where the source is algae, alfalfa or spinach.
5. The method according to claim 1 where the source is from the genus Spirulina .
6. The method according to claim 1 where the source is Spirulina pacifica.
7. The method according to claim 1 where the chlorophyll is greater than 95% pure.
8. The method according to claim 1 consisting essentially of liquid/solid extraction, liquid/liquid washing and centrifugal partition chromatography.
9. The method according to claim 1 further comprising forming a substantially pure chlorophyll derivative from the substantially pure chlorophyll.
10. The method according to claim 9 where the chlorophyll derivative has the structure depicted in Formula 1 or Formula 2, M is a metal ion with a charge of +2, R 1 is an aliphatic moiety, and R 2 -R 4 independently are aliphatic
11. The method according to claim 10 where M is selected from beryllium, magnesium, calcium, strontium, barium, chromium, manganese, iron, cobalt, nickel, copper, zinc, molybdenum, technetium, ruthenium, rhodium, palladium, cadmium, tungsten, rhenium, osmium, iridium, platinum, and mercury.
12. The method according to claim 10 where R 1 is an alkyl group having fewer than 10 carbon atoms.
13. A method for obtaining substantially pure chlorophyll a from a suitable source comprising:
providing a material containing chlorophylls;
extracting the material with methanol/petroleum ether (3:1 v/v);
filtering the extracted material and discarding solid particles to provide filtered extracted material;
washing the filtered extracted material with saturated sodium chloride to produce a first organic layer and a first aqueous layer;
washing the first organic layer with saturated sodium chloride to produce a second organic layer and a second aqueous layer;
filtering the second organic layer and evaporating organic solvent to produce a residue;
dissolving the residue in acetone; and
obtaining substantially pure chlorophyll a that is greater than 92% pure from dissolved residue by centrifugal partition chromatography using heptane as a stationary phase and ethanol as a mobile phase.